NCT05033535

s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

Efficacy and Safety of s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension:a Randomized,Double-blind,Placebo-controlled,Multicenter Phase II Clinical Trial

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: Shenzhen People's Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

Efficacy and Safety of s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension:a Randomized,Double-blind,Placebo-controlled,Multicenter Phase II Clinical Trial

Conditions

• Essential Hypertension

Interventions

Type	Name	Description
DRUG	Sacubatril Allisartan medoxomil	Sacubatril Allisartan medoxomil ：A randomized, double-blind, placebo and positive drug parallel controlled, multi-center phase II clinical study on the effectiveness and safety of treating mild and moderate essential hypertension
DRUG	Olmesartan Medoxomil	Efficacy for lowering blood pressure of Olmesartan medoxomil

Timeline

• Start date: 2020-07-01
• Primary completion: 2021-12-01
• Completion: 2022-06-30
• First posted: 2021-09-05
• Last updated: 2021-09-05

Locations

1 site across 1 country: China